Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myriad Genetics Inc MYGN

Healthcare Biotechnology
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has... see more

Recent & Breaking News (NDAQ:MYGN)

MYGN CLASS ACTION DEADLINE: Bernstein Liebhard LLP Announces the Filing of a Securities Class Action Against Myriad Genetics

PR Newswire October 1, 2019

MYRIAD DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Myriad Genetics, Inc. To Contact The Firm

Newsfile September 30, 2019

Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. (NASDAQ: MYGN) and Encourages Myriad Genetics Investors to Contact the Firm

Business Wire September 30, 2019

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire September 30, 2019

MYGN Loss Alert: Hagens Berman Notifies Investors in Myriad Genetics (MYGN) of Securities Fraud Lawsuit

PR Newswire September 30, 2019

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Myriad Genetics, Inc. (MYGN)

GlobeNewswire September 30, 2019

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - MYGN

PR Newswire September 30, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholder with Losses on their Investment in Myriad Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline - MYGN

ACCESSWIRE IA September 29, 2019

MYGN LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Myriad Genetics, Inc. - MYGN

Business Wire September 27, 2019

Pomerantz Law Firm Announces the Filing of a Class Action against Myriad Genetics, Inc. and Certain Officers - MYGN

GlobeNewswire September 27, 2019

Myriad Genetics Expands Board of Directors with Two Additional Members

GlobeNewswire September 25, 2019

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire September 25, 2019

MYGN INVESTIGATION REMINDER: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of the Firm's Ongoing Investigation of Possible Disclosure Violations

GlobeNewswire September 23, 2019

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire September 18, 2019

MYGN Loss Alert: Hagens Berman Reminds Myriad Genetics (MYGN) Investors of Ongoing Investigation for Possible Disclosure Violations

GlobeNewswire September 17, 2019

Lifshitz & Miller LLP Announces Investigation of 360 Finance, Inc., Canada Goose Holdings, Inc., Merit Medical Systems, Inc., Myriad Genetics, Inc., TenCent Music Entertainment Group, Two River Bancorp, UP Fintech Holding Limited, and X Financial

PR Newswire September 17, 2019

Myriad Announces Research Collaboration with University of Leeds

GlobeNewswire September 16, 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Myriad Genetics, Inc. - MYGN

GlobeNewswire September 12, 2019

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Myriad Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire September 11, 2019

Bronstein, Gewirtz & Grossman, LLC Announces Myriad Genetics, Inc. (MYGN) Investigation

ACCESSWIRE IA September 6, 2019